On August 20, Nordson rose 6.48% in pre-market trading, trading at $331.09/share, with turnover of $29,900.

The movement was driven by the company's fiscal Q3 earnings release, which significantly exceeded market expectations across all key metrics while management raised full-year guidance. Specifically, Nordson reported adjusted EPS of $3.25, beating the analyst consensus of $3.10 by approximately 4.8%, representing a 19.05% increase from $2.73 in the year-ago quarter. Quarterly revenue hit a record $817.67 million, surpassing the $780 million estimate and growing 10% year-over-year. Organic sales growth reached approximately 12%, driven by broad-based strength across all business segments.

Additionally, Nordson raised its fiscal 2026 full-year sales guidance to a range of $3.035 billion to $3.075 billion, well above the prior FactSet consensus estimate of $2.98 billion. The comprehensive beat on earnings, revenue, and forward guidance reflects accelerating momentum across the company's Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions segments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)